Global 3D Printing Drug Formulation and Administration Supply, Demand and Key Producers, 2023-2029

Global 3D Printing Drug Formulation and Administration Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 23 Aug 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global 3D Printing Drug Formulation and Administration market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global 3D Printing Drug Formulation and Administration demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for 3D Printing Drug Formulation and Administration, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 3D Printing Drug Formulation and Administration that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global 3D Printing Drug Formulation and Administration total market, 2018-2029, (USD Million)
Global 3D Printing Drug Formulation and Administration total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: 3D Printing Drug Formulation and Administration total market, key domestic companies and share, (USD Million)
Global 3D Printing Drug Formulation and Administration revenue by player and market share 2018-2023, (USD Million)
Global 3D Printing Drug Formulation and Administration total market by Type, CAGR, 2018-2029, (USD Million)
Global 3D Printing Drug Formulation and Administration total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global 3D Printing Drug Formulation and Administration market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, Merck KgaA, GlaxoSmithKline, Pfizer and Craft Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 3D Printing Drug Formulation and Administration market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global 3D Printing Drug Formulation and Administration Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global 3D Printing Drug Formulation and Administration Market, Segmentation by Type
MED
FDM
SSE
Other

Global 3D Printing Drug Formulation and Administration Market, Segmentation by Application
Drugs
Dietary Supplement

Companies Profiled:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health

Key Questions Answered
1. How big is the global 3D Printing Drug Formulation and Administration market?
2. What is the demand of the global 3D Printing Drug Formulation and Administration market?
3. What is the year over year growth of the global 3D Printing Drug Formulation and Administration market?
4. What is the total value of the global 3D Printing Drug Formulation and Administration market?
5. Who are the major players in the global 3D Printing Drug Formulation and Administration market?
btl

Table of Contents

1 Supply Summary
1.1 3D Printing Drug Formulation and Administration Introduction
1.2 World 3D Printing Drug Formulation and Administration Market Size & Forecast (2018 & 2022 & 2029)
1.3 World 3D Printing Drug Formulation and Administration Total Market by Region (by Headquarter Location)
1.3.1 World 3D Printing Drug Formulation and Administration Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.3 China 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.4 Europe 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.5 Japan 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.6 South Korea 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.7 ASEAN 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.8 India 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 3D Printing Drug Formulation and Administration Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 3D Printing Drug Formulation and Administration Major Market Trends

2 Demand Summary
2.1 World 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.2 World 3D Printing Drug Formulation and Administration Consumption Value by Region
2.2.1 World 3D Printing Drug Formulation and Administration Consumption Value by Region (2018-2023)
2.2.2 World 3D Printing Drug Formulation and Administration Consumption Value Forecast by Region (2024-2029)
2.3 United States 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.4 China 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.5 Europe 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.6 Japan 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.7 South Korea 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.8 ASEAN 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.9 India 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)

3 World 3D Printing Drug Formulation and Administration Companies Competitive Analysis
3.1 World 3D Printing Drug Formulation and Administration Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global 3D Printing Drug Formulation and Administration Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for 3D Printing Drug Formulation and Administration in 2022
3.2.3 Global Concentration Ratios (CR8) for 3D Printing Drug Formulation and Administration in 2022
3.3 3D Printing Drug Formulation and Administration Company Evaluation Quadrant
3.4 3D Printing Drug Formulation and Administration Market: Overall Company Footprint Analysis
3.4.1 3D Printing Drug Formulation and Administration Market: Region Footprint
3.4.2 3D Printing Drug Formulation and Administration Market: Company Product Type Footprint
3.4.3 3D Printing Drug Formulation and Administration Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: 3D Printing Drug Formulation and Administration Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: 3D Printing Drug Formulation and Administration Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: 3D Printing Drug Formulation and Administration Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: 3D Printing Drug Formulation and Administration Consumption Value Comparison
4.2.1 United States VS China: 3D Printing Drug Formulation and Administration Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: 3D Printing Drug Formulation and Administration Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based 3D Printing Drug Formulation and Administration Companies and Market Share, 2018-2023
4.3.1 United States Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
4.3.2 United States Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023)
4.4 China Based Companies 3D Printing Drug Formulation and Administration Revenue and Market Share, 2018-2023
4.4.1 China Based 3D Printing Drug Formulation and Administration Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023)
4.5 Rest of World Based 3D Printing Drug Formulation and Administration Companies and Market Share, 2018-2023
4.5.1 Rest of World Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World 3D Printing Drug Formulation and Administration Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 MED
5.2.2 FDM
5.2.3 SSE
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World 3D Printing Drug Formulation and Administration Market Size by Type (2018-2023)
5.3.2 World 3D Printing Drug Formulation and Administration Market Size by Type (2024-2029)
5.3.3 World 3D Printing Drug Formulation and Administration Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World 3D Printing Drug Formulation and Administration Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Drugs
6.2.2 Dietary Supplement
6.3 Market Segment by Application
6.3.1 World 3D Printing Drug Formulation and Administration Market Size by Application (2018-2023)
6.3.2 World 3D Printing Drug Formulation and Administration Market Size by Application (2024-2029)
6.3.3 World 3D Printing Drug Formulation and Administration Market Size by Application (2018-2029)

7 Company Profiles
7.1 Aprecia Pharmaceuticals
7.1.1 Aprecia Pharmaceuticals Details
7.1.2 Aprecia Pharmaceuticals Major Business
7.1.3 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product and Services
7.1.4 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Aprecia Pharmaceuticals Recent Developments/Updates
7.1.6 Aprecia Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Triastek
7.2.1 Triastek Details
7.2.2 Triastek Major Business
7.2.3 Triastek 3D Printing Drug Formulation and Administration Product and Services
7.2.4 Triastek 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Triastek Recent Developments/Updates
7.2.6 Triastek Competitive Strengths & Weaknesses
7.3 FabRx
7.3.1 FabRx Details
7.3.2 FabRx Major Business
7.3.3 FabRx 3D Printing Drug Formulation and Administration Product and Services
7.3.4 FabRx 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 FabRx Recent Developments/Updates
7.3.6 FabRx Competitive Strengths & Weaknesses
7.4 Multiply Labs
7.4.1 Multiply Labs Details
7.4.2 Multiply Labs Major Business
7.4.3 Multiply Labs 3D Printing Drug Formulation and Administration Product and Services
7.4.4 Multiply Labs 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Multiply Labs Recent Developments/Updates
7.4.6 Multiply Labs Competitive Strengths & Weaknesses
7.5 Merck KgaA
7.5.1 Merck KgaA Details
7.5.2 Merck KgaA Major Business
7.5.3 Merck KgaA 3D Printing Drug Formulation and Administration Product and Services
7.5.4 Merck KgaA 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck KgaA Recent Developments/Updates
7.5.6 Merck KgaA Competitive Strengths & Weaknesses
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Details
7.6.2 GlaxoSmithKline Major Business
7.6.3 GlaxoSmithKline 3D Printing Drug Formulation and Administration Product and Services
7.6.4 GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 GlaxoSmithKline Recent Developments/Updates
7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer 3D Printing Drug Formulation and Administration Product and Services
7.7.4 Pfizer 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Craft Health
7.8.1 Craft Health Details
7.8.2 Craft Health Major Business
7.8.3 Craft Health 3D Printing Drug Formulation and Administration Product and Services
7.8.4 Craft Health 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Craft Health Recent Developments/Updates
7.8.6 Craft Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 3D Printing Drug Formulation and Administration Industry Chain
8.2 3D Printing Drug Formulation and Administration Upstream Analysis
8.3 3D Printing Drug Formulation and Administration Midstream Analysis
8.4 3D Printing Drug Formulation and Administration Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World 3D Printing Drug Formulation and Administration Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World 3D Printing Drug Formulation and Administration Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World 3D Printing Drug Formulation and Administration Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World 3D Printing Drug Formulation and Administration Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World 3D Printing Drug Formulation and Administration Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World 3D Printing Drug Formulation and Administration Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World 3D Printing Drug Formulation and Administration Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key 3D Printing Drug Formulation and Administration Players in 2022
Table 12. World 3D Printing Drug Formulation and Administration Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global 3D Printing Drug Formulation and Administration Company Evaluation Quadrant
Table 14. Head Office of Key 3D Printing Drug Formulation and Administration Player
Table 15. 3D Printing Drug Formulation and Administration Market: Company Product Type Footprint
Table 16. 3D Printing Drug Formulation and Administration Market: Company Product Application Footprint
Table 17. 3D Printing Drug Formulation and Administration Mergers & Acquisitions Activity
Table 18. United States VS China 3D Printing Drug Formulation and Administration Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China 3D Printing Drug Formulation and Administration Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
Table 21. United States Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies 3D Printing Drug Formulation and Administration Revenue Market Share (2018-2023)
Table 23. China Based 3D Printing Drug Formulation and Administration Companies, Headquarters (Province, Country)
Table 24. China Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies 3D Printing Drug Formulation and Administration Revenue Market Share (2018-2023)
Table 26. Rest of World Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies 3D Printing Drug Formulation and Administration Revenue Market Share (2018-2023)
Table 29. World 3D Printing Drug Formulation and Administration Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World 3D Printing Drug Formulation and Administration Market Size by Type (2018-2023) & (USD Million)
Table 31. World 3D Printing Drug Formulation and Administration Market Size by Type (2024-2029) & (USD Million)
Table 32. World 3D Printing Drug Formulation and Administration Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World 3D Printing Drug Formulation and Administration Market Size by Application (2018-2023) & (USD Million)
Table 34. World 3D Printing Drug Formulation and Administration Market Size by Application (2024-2029) & (USD Million)
Table 35. Aprecia Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Aprecia Pharmaceuticals Major Business
Table 37. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product and Services
Table 38. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Aprecia Pharmaceuticals Recent Developments/Updates
Table 40. Aprecia Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Triastek Basic Information, Area Served and Competitors
Table 42. Triastek Major Business
Table 43. Triastek 3D Printing Drug Formulation and Administration Product and Services
Table 44. Triastek 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Triastek Recent Developments/Updates
Table 46. Triastek Competitive Strengths & Weaknesses
Table 47. FabRx Basic Information, Area Served and Competitors
Table 48. FabRx Major Business
Table 49. FabRx 3D Printing Drug Formulation and Administration Product and Services
Table 50. FabRx 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. FabRx Recent Developments/Updates
Table 52. FabRx Competitive Strengths & Weaknesses
Table 53. Multiply Labs Basic Information, Area Served and Competitors
Table 54. Multiply Labs Major Business
Table 55. Multiply Labs 3D Printing Drug Formulation and Administration Product and Services
Table 56. Multiply Labs 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Multiply Labs Recent Developments/Updates
Table 58. Multiply Labs Competitive Strengths & Weaknesses
Table 59. Merck KgaA Basic Information, Area Served and Competitors
Table 60. Merck KgaA Major Business
Table 61. Merck KgaA 3D Printing Drug Formulation and Administration Product and Services
Table 62. Merck KgaA 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck KgaA Recent Developments/Updates
Table 64. Merck KgaA Competitive Strengths & Weaknesses
Table 65. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 66. GlaxoSmithKline Major Business
Table 67. GlaxoSmithKline 3D Printing Drug Formulation and Administration Product and Services
Table 68. GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. GlaxoSmithKline Recent Developments/Updates
Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 71. Pfizer Basic Information, Area Served and Competitors
Table 72. Pfizer Major Business
Table 73. Pfizer 3D Printing Drug Formulation and Administration Product and Services
Table 74. Pfizer 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pfizer Recent Developments/Updates
Table 76. Craft Health Basic Information, Area Served and Competitors
Table 77. Craft Health Major Business
Table 78. Craft Health 3D Printing Drug Formulation and Administration Product and Services
Table 79. Craft Health 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of 3D Printing Drug Formulation and Administration Upstream (Raw Materials)
Table 81. 3D Printing Drug Formulation and Administration Typical Customers
List of Figure
Figure 1. 3D Printing Drug Formulation and Administration Picture
Figure 2. World 3D Printing Drug Formulation and Administration Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World 3D Printing Drug Formulation and Administration Total Market Size (2018-2029) & (USD Million)
Figure 4. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 13. 3D Printing Drug Formulation and Administration Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 16. World 3D Printing Drug Formulation and Administration Consumption Value Market Share by Region (2018-2029)
Figure 17. United States 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 18. China 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 23. India 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of 3D Printing Drug Formulation and Administration by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for 3D Printing Drug Formulation and Administration Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for 3D Printing Drug Formulation and Administration Markets in 2022
Figure 27. United States VS China: 3D Printing Drug Formulation and Administration Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: 3D Printing Drug Formulation and Administration Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World 3D Printing Drug Formulation and Administration Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World 3D Printing Drug Formulation and Administration Market Size Market Share by Type in 2022
Figure 31. MED
Figure 32. FDM
Figure 33. SSE
Figure 34. Other
Figure 35. World 3D Printing Drug Formulation and Administration Market Size Market Share by Type (2018-2029)
Figure 36. World 3D Printing Drug Formulation and Administration Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World 3D Printing Drug Formulation and Administration Market Size Market Share by Application in 2022
Figure 38. Drugs
Figure 39. Dietary Supplement
Figure 40. 3D Printing Drug Formulation and Administration Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global 3D Printing Drug Formulation and Administration Supply, Demand and Key Producers, 2023-2029

Global 3D Printing Drug Formulation and Administration Supply, Demand and Key Producers, 2023-2029

Page: 95

Published Date: 23 Aug 2023

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global 3D Printing Drug Formulation and Administration market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global 3D Printing Drug Formulation and Administration demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for 3D Printing Drug Formulation and Administration, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 3D Printing Drug Formulation and Administration that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global 3D Printing Drug Formulation and Administration total market, 2018-2029, (USD Million)
Global 3D Printing Drug Formulation and Administration total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: 3D Printing Drug Formulation and Administration total market, key domestic companies and share, (USD Million)
Global 3D Printing Drug Formulation and Administration revenue by player and market share 2018-2023, (USD Million)
Global 3D Printing Drug Formulation and Administration total market by Type, CAGR, 2018-2029, (USD Million)
Global 3D Printing Drug Formulation and Administration total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global 3D Printing Drug Formulation and Administration market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aprecia Pharmaceuticals, Triastek, FabRx, Multiply Labs, Merck KgaA, GlaxoSmithKline, Pfizer and Craft Health, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 3D Printing Drug Formulation and Administration market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global 3D Printing Drug Formulation and Administration Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global 3D Printing Drug Formulation and Administration Market, Segmentation by Type
MED
FDM
SSE
Other

Global 3D Printing Drug Formulation and Administration Market, Segmentation by Application
Drugs
Dietary Supplement

Companies Profiled:
Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health

Key Questions Answered
1. How big is the global 3D Printing Drug Formulation and Administration market?
2. What is the demand of the global 3D Printing Drug Formulation and Administration market?
3. What is the year over year growth of the global 3D Printing Drug Formulation and Administration market?
4. What is the total value of the global 3D Printing Drug Formulation and Administration market?
5. Who are the major players in the global 3D Printing Drug Formulation and Administration market?
btl

Table of Contents

1 Supply Summary
1.1 3D Printing Drug Formulation and Administration Introduction
1.2 World 3D Printing Drug Formulation and Administration Market Size & Forecast (2018 & 2022 & 2029)
1.3 World 3D Printing Drug Formulation and Administration Total Market by Region (by Headquarter Location)
1.3.1 World 3D Printing Drug Formulation and Administration Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.3 China 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.4 Europe 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.5 Japan 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.6 South Korea 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.7 ASEAN 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.3.8 India 3D Printing Drug Formulation and Administration Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 3D Printing Drug Formulation and Administration Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 3D Printing Drug Formulation and Administration Major Market Trends

2 Demand Summary
2.1 World 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.2 World 3D Printing Drug Formulation and Administration Consumption Value by Region
2.2.1 World 3D Printing Drug Formulation and Administration Consumption Value by Region (2018-2023)
2.2.2 World 3D Printing Drug Formulation and Administration Consumption Value Forecast by Region (2024-2029)
2.3 United States 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.4 China 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.5 Europe 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.6 Japan 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.7 South Korea 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.8 ASEAN 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)
2.9 India 3D Printing Drug Formulation and Administration Consumption Value (2018-2029)

3 World 3D Printing Drug Formulation and Administration Companies Competitive Analysis
3.1 World 3D Printing Drug Formulation and Administration Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global 3D Printing Drug Formulation and Administration Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for 3D Printing Drug Formulation and Administration in 2022
3.2.3 Global Concentration Ratios (CR8) for 3D Printing Drug Formulation and Administration in 2022
3.3 3D Printing Drug Formulation and Administration Company Evaluation Quadrant
3.4 3D Printing Drug Formulation and Administration Market: Overall Company Footprint Analysis
3.4.1 3D Printing Drug Formulation and Administration Market: Region Footprint
3.4.2 3D Printing Drug Formulation and Administration Market: Company Product Type Footprint
3.4.3 3D Printing Drug Formulation and Administration Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
4.1 United States VS China: 3D Printing Drug Formulation and Administration Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: 3D Printing Drug Formulation and Administration Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: 3D Printing Drug Formulation and Administration Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: 3D Printing Drug Formulation and Administration Consumption Value Comparison
4.2.1 United States VS China: 3D Printing Drug Formulation and Administration Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: 3D Printing Drug Formulation and Administration Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based 3D Printing Drug Formulation and Administration Companies and Market Share, 2018-2023
4.3.1 United States Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
4.3.2 United States Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023)
4.4 China Based Companies 3D Printing Drug Formulation and Administration Revenue and Market Share, 2018-2023
4.4.1 China Based 3D Printing Drug Formulation and Administration Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023)
4.5 Rest of World Based 3D Printing Drug Formulation and Administration Companies and Market Share, 2018-2023
4.5.1 Rest of World Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023)

5 Market Analysis by Type
5.1 World 3D Printing Drug Formulation and Administration Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 MED
5.2.2 FDM
5.2.3 SSE
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World 3D Printing Drug Formulation and Administration Market Size by Type (2018-2023)
5.3.2 World 3D Printing Drug Formulation and Administration Market Size by Type (2024-2029)
5.3.3 World 3D Printing Drug Formulation and Administration Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
6.1 World 3D Printing Drug Formulation and Administration Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Drugs
6.2.2 Dietary Supplement
6.3 Market Segment by Application
6.3.1 World 3D Printing Drug Formulation and Administration Market Size by Application (2018-2023)
6.3.2 World 3D Printing Drug Formulation and Administration Market Size by Application (2024-2029)
6.3.3 World 3D Printing Drug Formulation and Administration Market Size by Application (2018-2029)

7 Company Profiles
7.1 Aprecia Pharmaceuticals
7.1.1 Aprecia Pharmaceuticals Details
7.1.2 Aprecia Pharmaceuticals Major Business
7.1.3 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product and Services
7.1.4 Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Aprecia Pharmaceuticals Recent Developments/Updates
7.1.6 Aprecia Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Triastek
7.2.1 Triastek Details
7.2.2 Triastek Major Business
7.2.3 Triastek 3D Printing Drug Formulation and Administration Product and Services
7.2.4 Triastek 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Triastek Recent Developments/Updates
7.2.6 Triastek Competitive Strengths & Weaknesses
7.3 FabRx
7.3.1 FabRx Details
7.3.2 FabRx Major Business
7.3.3 FabRx 3D Printing Drug Formulation and Administration Product and Services
7.3.4 FabRx 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 FabRx Recent Developments/Updates
7.3.6 FabRx Competitive Strengths & Weaknesses
7.4 Multiply Labs
7.4.1 Multiply Labs Details
7.4.2 Multiply Labs Major Business
7.4.3 Multiply Labs 3D Printing Drug Formulation and Administration Product and Services
7.4.4 Multiply Labs 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Multiply Labs Recent Developments/Updates
7.4.6 Multiply Labs Competitive Strengths & Weaknesses
7.5 Merck KgaA
7.5.1 Merck KgaA Details
7.5.2 Merck KgaA Major Business
7.5.3 Merck KgaA 3D Printing Drug Formulation and Administration Product and Services
7.5.4 Merck KgaA 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Merck KgaA Recent Developments/Updates
7.5.6 Merck KgaA Competitive Strengths & Weaknesses
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Details
7.6.2 GlaxoSmithKline Major Business
7.6.3 GlaxoSmithKline 3D Printing Drug Formulation and Administration Product and Services
7.6.4 GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 GlaxoSmithKline Recent Developments/Updates
7.6.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.7 Pfizer
7.7.1 Pfizer Details
7.7.2 Pfizer Major Business
7.7.3 Pfizer 3D Printing Drug Formulation and Administration Product and Services
7.7.4 Pfizer 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pfizer Recent Developments/Updates
7.7.6 Pfizer Competitive Strengths & Weaknesses
7.8 Craft Health
7.8.1 Craft Health Details
7.8.2 Craft Health Major Business
7.8.3 Craft Health 3D Printing Drug Formulation and Administration Product and Services
7.8.4 Craft Health 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Craft Health Recent Developments/Updates
7.8.6 Craft Health Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 3D Printing Drug Formulation and Administration Industry Chain
8.2 3D Printing Drug Formulation and Administration Upstream Analysis
8.3 3D Printing Drug Formulation and Administration Midstream Analysis
8.4 3D Printing Drug Formulation and Administration Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World 3D Printing Drug Formulation and Administration Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World 3D Printing Drug Formulation and Administration Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World 3D Printing Drug Formulation and Administration Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World 3D Printing Drug Formulation and Administration Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World 3D Printing Drug Formulation and Administration Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World 3D Printing Drug Formulation and Administration Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World 3D Printing Drug Formulation and Administration Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key 3D Printing Drug Formulation and Administration Players in 2022
Table 12. World 3D Printing Drug Formulation and Administration Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global 3D Printing Drug Formulation and Administration Company Evaluation Quadrant
Table 14. Head Office of Key 3D Printing Drug Formulation and Administration Player
Table 15. 3D Printing Drug Formulation and Administration Market: Company Product Type Footprint
Table 16. 3D Printing Drug Formulation and Administration Market: Company Product Application Footprint
Table 17. 3D Printing Drug Formulation and Administration Mergers & Acquisitions Activity
Table 18. United States VS China 3D Printing Drug Formulation and Administration Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China 3D Printing Drug Formulation and Administration Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
Table 21. United States Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies 3D Printing Drug Formulation and Administration Revenue Market Share (2018-2023)
Table 23. China Based 3D Printing Drug Formulation and Administration Companies, Headquarters (Province, Country)
Table 24. China Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies 3D Printing Drug Formulation and Administration Revenue Market Share (2018-2023)
Table 26. Rest of World Based 3D Printing Drug Formulation and Administration Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies 3D Printing Drug Formulation and Administration Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies 3D Printing Drug Formulation and Administration Revenue Market Share (2018-2023)
Table 29. World 3D Printing Drug Formulation and Administration Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World 3D Printing Drug Formulation and Administration Market Size by Type (2018-2023) & (USD Million)
Table 31. World 3D Printing Drug Formulation and Administration Market Size by Type (2024-2029) & (USD Million)
Table 32. World 3D Printing Drug Formulation and Administration Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World 3D Printing Drug Formulation and Administration Market Size by Application (2018-2023) & (USD Million)
Table 34. World 3D Printing Drug Formulation and Administration Market Size by Application (2024-2029) & (USD Million)
Table 35. Aprecia Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. Aprecia Pharmaceuticals Major Business
Table 37. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Product and Services
Table 38. Aprecia Pharmaceuticals 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Aprecia Pharmaceuticals Recent Developments/Updates
Table 40. Aprecia Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Triastek Basic Information, Area Served and Competitors
Table 42. Triastek Major Business
Table 43. Triastek 3D Printing Drug Formulation and Administration Product and Services
Table 44. Triastek 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Triastek Recent Developments/Updates
Table 46. Triastek Competitive Strengths & Weaknesses
Table 47. FabRx Basic Information, Area Served and Competitors
Table 48. FabRx Major Business
Table 49. FabRx 3D Printing Drug Formulation and Administration Product and Services
Table 50. FabRx 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. FabRx Recent Developments/Updates
Table 52. FabRx Competitive Strengths & Weaknesses
Table 53. Multiply Labs Basic Information, Area Served and Competitors
Table 54. Multiply Labs Major Business
Table 55. Multiply Labs 3D Printing Drug Formulation and Administration Product and Services
Table 56. Multiply Labs 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Multiply Labs Recent Developments/Updates
Table 58. Multiply Labs Competitive Strengths & Weaknesses
Table 59. Merck KgaA Basic Information, Area Served and Competitors
Table 60. Merck KgaA Major Business
Table 61. Merck KgaA 3D Printing Drug Formulation and Administration Product and Services
Table 62. Merck KgaA 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Merck KgaA Recent Developments/Updates
Table 64. Merck KgaA Competitive Strengths & Weaknesses
Table 65. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 66. GlaxoSmithKline Major Business
Table 67. GlaxoSmithKline 3D Printing Drug Formulation and Administration Product and Services
Table 68. GlaxoSmithKline 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. GlaxoSmithKline Recent Developments/Updates
Table 70. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 71. Pfizer Basic Information, Area Served and Competitors
Table 72. Pfizer Major Business
Table 73. Pfizer 3D Printing Drug Formulation and Administration Product and Services
Table 74. Pfizer 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pfizer Recent Developments/Updates
Table 76. Craft Health Basic Information, Area Served and Competitors
Table 77. Craft Health Major Business
Table 78. Craft Health 3D Printing Drug Formulation and Administration Product and Services
Table 79. Craft Health 3D Printing Drug Formulation and Administration Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 80. Global Key Players of 3D Printing Drug Formulation and Administration Upstream (Raw Materials)
Table 81. 3D Printing Drug Formulation and Administration Typical Customers
List of Figure
Figure 1. 3D Printing Drug Formulation and Administration Picture
Figure 2. World 3D Printing Drug Formulation and Administration Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World 3D Printing Drug Formulation and Administration Total Market Size (2018-2029) & (USD Million)
Figure 4. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World 3D Printing Drug Formulation and Administration Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company 3D Printing Drug Formulation and Administration Revenue (2018-2029) & (USD Million)
Figure 13. 3D Printing Drug Formulation and Administration Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 16. World 3D Printing Drug Formulation and Administration Consumption Value Market Share by Region (2018-2029)
Figure 17. United States 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 18. China 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 23. India 3D Printing Drug Formulation and Administration Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of 3D Printing Drug Formulation and Administration by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for 3D Printing Drug Formulation and Administration Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for 3D Printing Drug Formulation and Administration Markets in 2022
Figure 27. United States VS China: 3D Printing Drug Formulation and Administration Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: 3D Printing Drug Formulation and Administration Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World 3D Printing Drug Formulation and Administration Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World 3D Printing Drug Formulation and Administration Market Size Market Share by Type in 2022
Figure 31. MED
Figure 32. FDM
Figure 33. SSE
Figure 34. Other
Figure 35. World 3D Printing Drug Formulation and Administration Market Size Market Share by Type (2018-2029)
Figure 36. World 3D Printing Drug Formulation and Administration Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World 3D Printing Drug Formulation and Administration Market Size Market Share by Application in 2022
Figure 38. Drugs
Figure 39. Dietary Supplement
Figure 40. 3D Printing Drug Formulation and Administration Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Aprecia Pharmaceuticals
Triastek
FabRx
Multiply Labs
Merck KgaA
GlaxoSmithKline
Pfizer
Craft Health
jiaGou

Add To Cart

gouMai

Buy Now